<--- Back to Details
First PageDocument Content
Anatomy / Immunosuppressants / Monoclonal antibodies / Abdominal pain / Arthritis / Infliximab / Adalimumab / Ulcerative colitis / Ankylosing spondylitis / Medicine / Health / Autoimmune diseases
Date: 2015-01-19 17:21:09
Anatomy
Immunosuppressants
Monoclonal antibodies
Abdominal pain
Arthritis
Infliximab
Adalimumab
Ulcerative colitis
Ankylosing spondylitis
Medicine
Health
Autoimmune diseases

July 2014 PBAC OUTCOMES - "Subsequent" Decisions not to Recommend Drug Name, form(s), strength(s), Sponsor, Type of submission TGA Indication Current PBS Listing

Add to Reading List

Source URL: www.pbs.gov.au

Download Document from Source Website

File Size: 33,39 KB

Share Document on Facebook

Similar Documents

BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi

BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi

DocID: 1rrNB - View Document

Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2

Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2

DocID: 1rmwo - View Document

EAP Reimbursement Criteria for Frequently Requested Drugs

EAP Reimbursement Criteria for Frequently Requested Drugs

DocID: 1rhhE - View Document

UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include:  Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol

UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include:  Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol

DocID: 1rakB - View Document

TABLE OF CONTENTS  INTRODUCTION 2

TABLE OF CONTENTS INTRODUCTION 2

DocID: 1qY7G - View Document